Koivistro-Korander et al. also demonstrated that expression of these hormone receptors was associated with therapeutic outcomes; ER/PR-positive ESS, LMS, and CS patients tended to have longer PFS and OS [14]. The gene discussed is ESR1; the disease is Cowden syndrome 1.